Enhanced Diagnosis of Generalized Pustular Psoriasis With the Legit.Health Device as a Diagnosis Support Tool: Multireader Multicase Study - Top-Institutions - MDSpire

Enhanced Diagnosis of Generalized Pustular Psoriasis With the Legit.Health Device as a Diagnosis Support Tool: Multireader Multicase Study

  • By

  • Alfonso Medela

  • Ignacio Hernández Montilla

  • Alberto Sabater

  • Andy Aguilar

  • Taig Mac Carthy

  • Gurpreet Singh Chowdhry

  • Juan Semeco

  • Antonio Martorell

  • June 10, 2026

  • 0 min

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai

    New York, New York

    Key Differentiators

    • Dermatology

  • #2

    University of Michigan
    University of Michigan

    Ann Arbor, Michigan

    Key Differentiators

    • Dermatology

  • #3

    Semmelweis University
    Semmelweis University

    Budapest, Hungary

    Key Differentiators

    • Dermatology

  • #4

    Shenzhen Children’s Hospital
    Shenzhen Children’s Hospital

    Shenzhen, China

    Key Differentiators

    • Pediatrics
    • Dermatology

  • #5

    German Cancer Research Center
    German Cancer Research Center

    Heidelberg, Germany

    Key Differentiators

    • Dermatology

Original Source(s)

Enhanced Diagnosis of Generalized Pustular Psoriasis With the Legit.Health Device as a Diagnosis Support Tool: Multireader Multicase Study

  • by Alfonso Medela, Ignacio Hernández Montilla, Alberto Sabater, Andy Aguilar, Taig Mac Carthy, Gurpreet Singh Chowdhry, Juan Semeco, Antonio Martorell

  • June 10, 2026

Related Content

Ivarmacitinib Eased Refractory PCA: Case Report

Off-label ivarmacitinib rapidly relieved pruritus and improved skin lesions in a patient with refractory primary cutaneous amyloidosis, according to a case report.

Rare Skin Reaction Reported With Tirzepatide

A single case report described possible lichen planus pigmentosus inversus following tirzepatide initiation.

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.